"Ibrance (Palbociclib) is an oral medication used in combination with other therapies to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer."
2- "Lynparza (Olaparib) is a targeted therapy used to treat breast cancer as well as certain other cancers."
"Lynparza (Olaparib) is an oral PARP inhibitor used to treat BRCA-mutated breast cancer and other cancers, including ovarian and pancreatic cancers."
3- "Imbruvica (Ibrutinib) is a targeted therapy used to treat various types of blood cancers."
"Imbruvica (Ibrutinib) is a Bruton’s tyrosine kinase (BTK) inhibitor used in the treatment of several blood cancers, including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström’s macroglobulinemia."
4- "Opdivo (Nivolumab) is an immunotherapy drug used to treat lung cancer, melanoma, and various other cancers."
"Opdivo (Nivolumab) is a PD-1 immune checkpoint inhibitor used in the treatment of non-small cell lung cancer, melanoma, and several other cancers."
5- "Keytruda (Pembrolizumab) is an immunotherapy medication used to treat lung cancer, melanoma, and various other cancers."
"Keytruda (Pembrolizumab) is a PD-1 inhibitor used in the treatment of non-small cell lung cancer, melanoma, and multiple other cancers by enhancing the body’s immune response."
6- "Herceptin (Trastuzumab) is a targeted therapy used to treat HER2-positive breast cancer."
"Herceptin (Trastuzumab) is a monoclonal antibody that targets HER2 receptors, used in the treatment of HER2-positive breast cancer."
7- "Zejula (Niraparib) is a targeted therapy used to treat ovarian cancer and certain other cancers."
"Zejula (Niraparib) is a PARP inhibitor used in the treatment of ovarian cancer and other cancers with specific genetic mutations."
8- "Tagrisso (Osimertinib) is a targeted therapy used to treat non-small cell lung cancer."
"Tagrisso (Osimertinib) is a third-generation EGFR inhibitor used for the treatment of non-small cell lung cancer with specific EGFR mutations."
9- "Votrient (Pazopanib) is a targeted therapy used to treat kidney cancer and certain other cancers."
"Votrient (Pazopanib) is a tyrosine kinase inhibitor used for the treatment of advanced kidney cancer and soft tissue sarcomas."
10- "Stivarga (Regorafenib) is a targeted therapy used to treat colorectal cancer and certain other cancers."
"Stivarga (Regorafenib) is a multi-kinase inhibitor used for the treatment of metastatic colorectal cancer and other advanced cancers."
North America:
United States, Canada, Mexico
Latin America:
Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Ecuador, Bolivia, Uruguay, Paraguay, Costa Rica, Panama, Guatemala, Honduras, El Salvador, Nicaragua, Belize, Cuba, Dominican Republic, Haiti, Jamaica, Trinidad and Tobago, and all other countries in the region.
Southern Africa:
South Africa, Namibia, Botswana, Zimbabwe, Lesotho, Eswatini (Swaziland), Angola, Zambia, Mozambique, Malawi, and neighboring countries.
Middle East:
Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Bahrain, Oman, Iraq, Jordan, Lebanon, Syria, Yemen, Israel, Palestine, Iran, Turkey, and all other countries in the region.
Contact
www.ernestpharmaceuticals.com
www.ernestimpex.com
exports@ernestpharmaceuticals.com
WhatsApp Number
+91 94054 76170, +91 93599 02383